Gestational trophoblastic disease with multisistemic complications
Author(s) -
DEJAN PEJIĆ,
Sasa Savic,
M Popović,
Arnela Banićević,
BARBARA STANIMIROVIĆ,
Jelena Mrđa
Publication year - 2015
Publication title -
signa vitae
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 7
eISSN - 1845-206X
pISSN - 1334-5605
DOI - 10.22514/sv101.062015.24
Subject(s) - partial hydatidiform mole , medicine , mole , gestational trophoblastic disease , etiology , gynecology , placental site trophoblastic tumor , obstetrics , human chorionic gonadotropin , conceptus , pregnancy , gestation , fetus , placenta , biology , hormone , genetics
Gestational trophoblastic disease (GTD) is a condition of uncertain etiology, comprised of a hydatidiform mole (complete and partial), invasive mole, choriocarcinoma, epithelioid trophoblastic tumour and placental site trophoblastic tumour. A partial hydatidiform mole develops when dispermy occurs, and the resulting conceptus is triploidy. A 26-year-old woman (Gravida 2, Para 1, with one previous vaginal delivery of a normal female infant) was 16 weeks pregnant and was scheduled for emergency surgical treatment. She was diagnosed with a hydatidiform mole and eclampsia in our hospital for further treatment. Her pre-treatment beta human chorionic gonadotropin (β-HCG) level was extremely high at 1,082,900 mIU/ml. The obstetricians considered septic complications from the hydatidiform mole and we decided to perform an emergency Sectio parva. Two weeks after delivery, the serum β-hCG level was 16,341 mlU/mL and normalized gradually within two months without any cytotoxic therapy. Partial mole hydatidosa (PMH), as a milder form of GTD, can go along with malignant complications with fatal consequences.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom